PromarkerD diabetic kidney disease test launched in Spain
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- PromarkerD test ready for launch in Europe
- Appendix 4C - June 2019 Quarterly Report
- Proteomics secures contracts for pharmacokinetic analysis
- Appendix 4C - March 2019 Quarterly Report
- US patent for identifying drugs for abnormal kidney function
Later from Proteomics International Laboratories
- PromarkerD IVD successfully developed and validated
- Appendix 4C - September 2019 Quarterly Report
- CE Mark for predictive test for diabetic kidney disease
- Proteomics raises $3m in heavily oversubscribed Placement
- Partnership provides funding for cutting-edge facility
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories